Linda Birr-Pixton

Dear Medicines and Healthcare Products Regulatory Agency,
Could you please state your position regarding the use of the now deleted test the Abnormal Toxicity Test?
I would be grateful for the written statement regarding this test.
What position does the MHRA in ensuring that contracted research labs are no longer using deleted safety tests here in the UK such as the ATT?
Can I ask how that position works with providing research labs with GLP compliance certification?

Yours faithfully,

Linda Birr-Pixton

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Experience
Centre Team. We will respond to you as soon as possible.

 

Please note that we may not respond if your query:

·         contains offensive language

·         has already been answered in a previous reply to you

·         is illegible

·         is selling or promoting a product

·         is for information only

 

Kind regards

MHRA Customer Experience Centre

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU

DISCLAIMER This email and any files transmitted with it are confidential.
If you are not the intended recipient, any reading, printing, storage,
disclosure, copying or any other action taken in respect of this email is
prohibited and may be unlawful. If you are not the intended recipient,
please notify the sender immediately by using the reply function and then
permanently delete what you have received. Incoming and outgoing email
messages are routinely monitored for compliance with the Department of
Health's policy on the use of electronic communications. For more
information on the Department of Health's email policy, click
[1]DHTermsAndConditions

References

Visible links
1. file:///tmp/%20https:/www.gov.uk/help/terms-conditions

FOI Team, Medicines and Healthcare Products Regulatory Agency

MHRA reference: FOI2024/00492

Dear Linda Birr-Pixton,

Thank you for your information request, which we received on 31 August. We
have understood your request to be for the following information:

Could you please state your position regarding the use of the now deleted
test the Abnormal Toxicity Test?
I would be grateful for the written statement regarding this test.
What position does the MHRA in ensuring that contracted research labs are
no longer using deleted safety tests here in the UK such as the ATT?
Can I ask how that position works with providing research labs with GLP
compliance certification?

If we have misunderstood or misinterpreted your request, please contact us
as soon as possible.

We will deal with your request under the Freedom of Information Act 2000
(FOIA). The statutory time frame for response is 20 working days; this
begins on the first working day after receipt, and we will respond by 27th
September.

If you need to contact us about this request, please quote the reference
number above.

We publish our responses to FOI requests with requester details removed.
You can view these on our website here:

[1]Transparency and freedom of information releases - GOV.UK (www.gov.uk)

Yours sincerely

Healthcare, Quality and Access Group

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 020 3080 6000

[2]gov.uk/mhra

[3]Stay connected

For information on how the Agency uses your personal data and your data
protection rights, please see our three centres' Privacy Notices: [4]MHRA,
[5]CPRD and [6]NIBSC.

Appeal rights

If you are dissatisfied with the handling of your request, you have the
right to ask for an internal review. Internal review requests should be
submitted within two months of the date you receive this response and
addressed to: [email address]

If you remain dissatisfied with the outcome of the internal review, you
have the right to apply directly to the Information Commissioner for a
decision. Please bear in mind that the Information Commissioner will not
normally review our handling of a request unless the requester has first
asked us to conduct an internal review.

The Information Commissioner can be contacted through their online webform
at:
[7]https://ico.org.uk/make-a-complaint/foi-...

Or in writing to: Information Commissioner's Office, Wycliffe House, Water
Lane, Wilmslow, Cheshire, SK9 5AF

References

Visible links
1. https://eur01.safelinks.protection.outlo...
2. https://eur01.safelinks.protection.outlo...
3. https://eur01.safelinks.protection.outlo...
4. https://eur01.safelinks.protection.outlo...
5. https://eur01.safelinks.protection.outlo...
6. https://eur01.safelinks.protection.outlo...
7. file:///tmp/http:/about:blank/

FOI Team, Medicines and Healthcare Products Regulatory Agency

1 Attachment

Dear Linda Birr-Pixton,

I am writing in response to your request for information, received 31st
August.

Please find the response to your request attached.

Yours sincerely,

Healthcare, Quality and Access Group

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 020 3080 6000

[1]gov.uk/mhra

[2]Stay connected

For information on how the Agency uses your personal data and your data
protection rights, please see our three centres' Privacy Notices: [3]MHRA,
[4]CPRD and [5]NIBSC.

References

Visible links
1. https://eur01.safelinks.protection.outlo...
2. https://eur01.safelinks.protection.outlo...
3. https://eur01.safelinks.protection.outlo...
4. https://eur01.safelinks.protection.outlo...
5. https://eur01.safelinks.protection.outlo...